A postdoctoral position is available starting October 2017 in the laboratory of Dr. Elvire Gouze to develop a biotherapy for type II collagenopathy, a rare disease leading to severe dwarfism. Patients with spondyloepiphyseal dysplasia congenita (SEDc) have very severe skeletal deformities and also suffer form retinal alterations and hearing loss. The goal of this project is to develop an ex vivo gene therapy approach to correct bone growth in a murine model of SEDc.
The group is located at the beautiful Valrose Campus in the heart of Nice. The group is part of the iBV, an international research centre that brings together high-profile teams with complementary areas of expertise and with a common interest in translating basic research into knowledge for the clinic.
Scientific staff has access to state of the art facilities including imaging/microscopy and cytometry platforms, L2 and L3 laboratories, and histology and biochemistry facilities.
For more information, visit http://ibv.unice.fr
The position is available for 1 year that can be extended upon results.
Interested individuals should send a C.V., a motivation letter and names of three references to Dr Elvire Gouze, iBV, Parc Valrose, Bat Sci Nat 8ème étage, Université Nice Sophia Antipolis, 06108 Nice Cedex 2, France
Tel : +33 (0)4 92 07 67 43